Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIGADEXA Gel vs Solution for Post-Cataract Surgery Inflammation and Infection
NCT01515826Phase 3Withdrawn
- Sponsor
- Alcon Inc.
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules, Device-based Delivery
01
Overview
A Phase 3 trial of Moxisurge, dexamethasone iontophoretic patch in post-operative inflammation, post-operative infection, sponsored by Alcon Inc.. Planned start Mar 2014; status: withdrawn.
02
Drugs
Moxisurgedexamethasone iontophoretic patch
03
Conditions
post-operative inflammationpost-operative infection
Beyond the preview
Go deeper on NCT01515826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01515826.